Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith C Ferdinand

Showing results (171-180 of 287) with videos related to

Pageof 29
Sort By:
American Heart Journal|December 16, 2014
Left ventricular hypertrophy and cardiovascular disease risk prediction and reclassification in blacks and whites: the Atherosclerosis Risk in Communities StudyTochi M Okwuosa, Elsayed Z Soliman, Faye Lopez, et al.
Hypertension (Dallas, Tex. : 1979)|August 24, 2005
A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensivesMatthew R Weir, Keith C Ferdinand, John M Flack, et al.
Circulation|February 22, 2019
Antihyperglycemic and Blood Pressure Effects of Empagliflozin in Black Patients With Type 2 Diabetes Mellitus and HypertensionKeith C Ferdinand, Joseph L Izzo, Jisoo Lee, et al.
Biomedicines|May 4, 2026
Integrating GLP-1 Receptor Agonists into Modern Stroke Prevention: Evidence, Mechanisms, and Clinical Consideration-A Narrative ReviewShayan Khan, William Herbst, Farbod Zahedi Tajrishi, et al.
Journal of the National Medical Association|December 23, 2023
Life's essential eight as targets for cardiometabolic risk reduction among non-Hispanic black adults: A primary care approachEbubechukwu Ezeh, Onyedika Ilonze, Maddie Perdoncin, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|July 14, 2011
The impact of lipoic acid on endothelial function and proteinuria in quinapril-treated diabetic patients with stage I hypertension: results from the QUALITY studySyed T Rahman, Nadya Merchant, Tahir Haque, et al.
Hypertension (Dallas, Tex. : 1979)|September 14, 2011
Progression is accelerated from prehypertension to hypertension in blacksAnbesaw Selassie, C Shaun Wagner, Marilyn L Laken, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 27, 2012
Community-based approaches to prevention and management of hypertension and cardiovascular diseaseKeith C Ferdinand, Kellee P Patterson, Cheryl Taylor, et al.
Circulation. Cardiovascular Interventions|July 9, 2015
Ticagrelor Versus Clopidogrel in Black Patients With Stable Coronary Artery Disease: Prospective, Randomized, Open-Label, Multiple-Dose, Crossover Pilot StudyRon Waksman, Juan Maya, Dominick J Angiolillo, et al.
Journal of the American Society of Hypertension : JASH|July 10, 2013
Changes in biomarkers and 24 hours blood pressure in hypertensive African Americans with the metabolic syndrome: comparison of amlodipine/olmesartan versus hydrochlorothiazide/losartanNadya Merchant, Syed T Rahman, Mushtaq Ahmad, et al.
Pageof 29

Showing results (171-180 of 287) with videos related to

Sort By:
Pageof 29
American Heart Journal|December 16, 2014
Left ventricular hypertrophy and cardiovascular disease risk prediction and reclassification in blacks and whites: the Atherosclerosis Risk in Communities StudyTochi M Okwuosa, Elsayed Z Soliman, Faye Lopez, et al.
Hypertension (Dallas, Tex. : 1979)|August 24, 2005
A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensivesMatthew R Weir, Keith C Ferdinand, John M Flack, et al.
Circulation|February 22, 2019
Antihyperglycemic and Blood Pressure Effects of Empagliflozin in Black Patients With Type 2 Diabetes Mellitus and HypertensionKeith C Ferdinand, Joseph L Izzo, Jisoo Lee, et al.
Biomedicines|May 4, 2026
Integrating GLP-1 Receptor Agonists into Modern Stroke Prevention: Evidence, Mechanisms, and Clinical Consideration-A Narrative ReviewShayan Khan, William Herbst, Farbod Zahedi Tajrishi, et al.
Journal of the National Medical Association|December 23, 2023
Life's essential eight as targets for cardiometabolic risk reduction among non-Hispanic black adults: A primary care approachEbubechukwu Ezeh, Onyedika Ilonze, Maddie Perdoncin, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|July 14, 2011
The impact of lipoic acid on endothelial function and proteinuria in quinapril-treated diabetic patients with stage I hypertension: results from the QUALITY studySyed T Rahman, Nadya Merchant, Tahir Haque, et al.
Hypertension (Dallas, Tex. : 1979)|September 14, 2011
Progression is accelerated from prehypertension to hypertension in blacksAnbesaw Selassie, C Shaun Wagner, Marilyn L Laken, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 27, 2012
Community-based approaches to prevention and management of hypertension and cardiovascular diseaseKeith C Ferdinand, Kellee P Patterson, Cheryl Taylor, et al.
Circulation. Cardiovascular Interventions|July 9, 2015
Ticagrelor Versus Clopidogrel in Black Patients With Stable Coronary Artery Disease: Prospective, Randomized, Open-Label, Multiple-Dose, Crossover Pilot StudyRon Waksman, Juan Maya, Dominick J Angiolillo, et al.
Journal of the American Society of Hypertension : JASH|July 10, 2013
Changes in biomarkers and 24 hours blood pressure in hypertensive African Americans with the metabolic syndrome: comparison of amlodipine/olmesartan versus hydrochlorothiazide/losartanNadya Merchant, Syed T Rahman, Mushtaq Ahmad, et al.
Pageof 29